The FDA regulates Bpc-157 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use
Until well-designed clinical trials are conducted, BPC-157 should be considered investigational, and its use approached with caution
Many clinicians consider anti-obesity medications after the initial rapid weight loss phase, typically 6-12 months post-operatively, or when patients experience a plateau or weight regain despite adherence to post-surgical recommendations
Kyle Gillette, a physician specializing in peptide therapy, broke down exactly what these compounds are, how they work, and which ones might actually help with recovery
Peptides can also be part of a long-term hormone optimization strategy
Your skin is not a dirty wok